Amyloid-β (Aβ1–42), total-tau (tau) and phospho-tau (p-tau) are currently used as suitable cerebrospinal fluid (CSF) biomarkers to detect AD [3]. The gene discussed is MAPT; the disease is Alzheimer disease.